Bloomberg News has reported that Eli Lilly, Merck, and other large drugmakers had a combined sales increase of $2.5 billion last year, and part D providers such as Wellpoint, Aetna and their business rivals gained $1 billion in sales ...
manfredeye.com/?p=151
